Decoding the Healthcare Tech Term Sheet: A Practical Guide to Understanding the Money Behind the Medicine

Oct 28, 2025

∙ Paid

Welcome to Healthcare Markets & Technology.

Rigorous analysis of AI, policy, capital, technology, and clinical operations across U.S. healthcare — written for the people who build, invest in, and lead it.

Free subscribers get 2 public articles per week. Upgrade to paid → for the full 7 articles/week, paid podcast episodes, deal breakdowns, and the complete 538-deep-dive archive.

Subscribe or upgrade here →

One thing to bookmark: the searchable Knowledge Base at kb.onhealthcare.tech isn’t in Substack’s menu. Save it now — on mobile, tap share → “Add to Home Screen.”

Reply to any email with questions. I read every one.

— Trey

Abstract

This essay provides a comprehensive exploration of term sheet mechanics for healthcare technology investments, examining the critical components that define the relationship between founders and investors. The abstract outlines the key areas covered: valuation methodologies specific to health tech companies, including both traditional and SAFE note structures; preference stack architecture and its implications for exit scenarios; pro rata rights and their strategic importance; anti-dilution provisions and their mathematical impact on ownership; and the interplay between governance terms and operational control. The essay draws on specific examples from recent healthcare technology financings to illustrate how seemingly minor term sheet provisions can create major downstream consequences for both founders and investors. Special attention is paid to health tech-specific considerations, including regulatory risk allocation, data security provisions, and customer concentration clauses that differentiate these deals from standard software investments.

I. Introduction: Why Term Sheets Matter More in Healthcare Technology

II. Valuation Mechanisms: Caps, Discounts, and the SAFE Note Evolution

III. Preference Stacks: Understanding the Liquidation Waterfall

IV. Anti-Dilution Protection: Full Ratchet versus Weighted Average

V. Pro Rata Rights and the Signaling Game

VI. Control Provisions: Board Composition and Protective Covenants

VII. Healthcare-Specific Terms: Regulatory Contingencies and Data Provisions

VIII. Case Studies: When Terms Drive Outcomes

IX. Conclusion: Building Alignment Through Thoughtful Negotiation